349 related articles for article (PubMed ID: 28279072)
1. Aspirin in Older Adults: Need for Wider Utilization in Secondary Prevention and Individual Clinical Judgments in Primary Prevention.
Sehgal M; Wood SK; Ouslander JG; Hennekens CH
J Cardiovasc Pharmacol Ther; 2017 Nov; 22(6):511-513. PubMed ID: 28279072
[TBL] [Abstract][Full Text] [Related]
2. Aspirin in the treatment and prevention of cardiovascular disease: past and current perspectives and future directions.
Hennekens CH; Dalen JE
Am J Med; 2013 May; 126(5):373-8. PubMed ID: 23499330
[TBL] [Abstract][Full Text] [Related]
3. Aspirin in the primary prevention of cardiovascular disease: current knowledge and future research needs.
Hennekens CH; Dalen JE
Trends Cardiovasc Med; 2014 Nov; 24(8):360-6. PubMed ID: 25444455
[TBL] [Abstract][Full Text] [Related]
4. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
Hennekens CH; Schneider WR
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
[TBL] [Abstract][Full Text] [Related]
5. Update on aspirin in the treatment and prevention of cardiovascular disease.
Hennekens CH
Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
[TBL] [Abstract][Full Text] [Related]
6. Aspirin in the Prevention of Cardiovascular Disease and Cancer.
Ricciotti E; FitzGerald GA
Annu Rev Med; 2021 Jan; 72():473-495. PubMed ID: 33502899
[TBL] [Abstract][Full Text] [Related]
7. Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease: Advances in Diagnosis and Treatment.
Mora S; Manson JE
JAMA Intern Med; 2016 Aug; 176(8):1195-204. PubMed ID: 27322595
[TBL] [Abstract][Full Text] [Related]
8. Aspirin for primary prevention: yes or no?
Selak V; Elley CR; Wells S; Rodgers A; Sharpe N
J Prim Health Care; 2010 Jun; 2(2):92-9. PubMed ID: 20690297
[TBL] [Abstract][Full Text] [Related]
9. When is the use of aspirin for CVD prevention in women appropriate?
Manson JE; Bassuk SS
Menopause; 2014 Jan; 21(1):103-5. PubMed ID: 23695505
[TBL] [Abstract][Full Text] [Related]
10. A review and study of aspirin utilization for the primary prevention of cardiovascular events in a psychiatric population.
Victor K; Skelly M; Mulcahy K; Demler TL; Trigoboff E
Int Clin Psychopharmacol; 2018 Sep; 33(5):274-281. PubMed ID: 29939889
[TBL] [Abstract][Full Text] [Related]
11. Are the current recommendations for the use of aspirin in primary prevention of cardiovascular disease applicable in low-income countries?
Noubiap JJ; Nansseu JR
Vasc Health Risk Manag; 2015; 11():503-6. PubMed ID: 26345154
[TBL] [Abstract][Full Text] [Related]
12. The use of aspirin for primary and secondary prevention in venous thromboembolism and other cardiovascular disorders.
Cohen AT; Imfeld S; Markham J; Granziera S
Thromb Res; 2015 Feb; 135(2):217-25. PubMed ID: 25541030
[TBL] [Abstract][Full Text] [Related]
13. [Italian intersocietary consensus document on aspirin therapy in primary cardiovascular prevention].
Volpe M; Abrignani MG; Borghi C; Coccheri S; Gresele P; Patti G; Trimarco B; De Caterina R
G Ital Cardiol (Rome); 2014; 15(7-8):442-51. PubMed ID: 25174598
[TBL] [Abstract][Full Text] [Related]
14. Budget Impact of Appropriate Low-Dose Aspirin Use for Primary and Secondary Cardiovascular Event Prevention in the Managed Care Setting.
Carlton R; Coppolecchia R; Khalaf-Gillard K; Lennert B; Moradi A; Williamson T; Cameron J
J Manag Care Spec Pharm; 2018 Nov; 24(11):1102-1111. PubMed ID: 30362916
[TBL] [Abstract][Full Text] [Related]
15. Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement.
Bibbins-Domingo K;
Ann Intern Med; 2016 Jun; 164(12):836-45. PubMed ID: 27064677
[TBL] [Abstract][Full Text] [Related]
16. Aspirin for primary prevention of cardiovascular disease events.
Nemerovski CW; Salinitri FD; Morbitzer KA; Moser LR
Pharmacotherapy; 2012 Nov; 32(11):1020-35. PubMed ID: 23019080
[TBL] [Abstract][Full Text] [Related]
17. An aspirin a day? Aspirin use across a spectrum of risk: cardiovascular disease, cancers and bleeds.
Kolber MR; Korownyk C
Expert Opin Pharmacother; 2014 Feb; 15(2):153-7. PubMed ID: 24206142
[TBL] [Abstract][Full Text] [Related]
18. Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: Benefit or risk?
Leggio M; Bendini MG; Caldarone E; Lombardi M; Severi P; D'Emidio S; Stavri DC; Armeni M; Bravi V; Mazza A
Diabetes Metab; 2018 Jun; 44(3):217-225. PubMed ID: 29257747
[TBL] [Abstract][Full Text] [Related]
19. Investigating the effectiveness of different aspirin dosing regimens and the timing of aspirin intake in primary and secondary prevention of cardiovascular disease: protocol for a systematic review.
Bem D; Dretzke J; Stevens S; Lordkipanidzé M; Hodgkinson J; Bayliss S; Moore D; Fitzmaurice D
Syst Rev; 2015 Jun; 4():88. PubMed ID: 26088608
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
